Triamcinolone Acetonide (TA)

DRUG5 trials

Sponsors

Biosplice Therapeutics, Inc., Campbell Clinic, Rumah Sakit Pusat Angkatan Darat Gatot Soebroto, Anggun Rama Yudantha

Conditions

Drug-Drug InteractionKeloidProliferative Vitreoretinopathy in Rhegmatogenous Retinal DetachmentShoulder PainStem Cell

Phase 1

Drug-Drug Interaction Study of Lorecivivint and Triamcinolone Acetonide in Healthy Volunteers

CompletedNCT04598542

Biosplice Therapeutics, Inc.Drug-Drug Interaction

Start: 2020-10-13End: 2020-12-22Updated: 2021-01-12

Phase 4

Pain Increases After Shoulder Injection

CompletedNCT05438277

Campbell ClinicShoulder Pain

Start: 2020-01-01End: 2022-09-30Updated: 2023-03-07

Comparison of Keloid Volume and Symptoms Reduction Between Intralesional Umbilical-Cord Mesenchymal Stem Cells, Its Conditioned Medium, and Triamcinolone Acetonide Injection as Keloid Therapy: A Randomised Controlled Trial

CompletedNCT05887804

Rumah Sakit Pusat Angkatan Darat Gatot SoebrotoKeloid, Stem Cell

Start: 2021-10-01End: 2022-06-09Updated: 2023-06-07

The Effect of Intralesian Injection of Umbilical Cord Mesenchymal Stem Cells, Its Conditioned Medium, and Triamcinolone Acetonide on Type 1:3 Collagen Ratio and Interleukin-10 Levels in Keloid: A Randomised Controlled Trial

CompletedNCT05939817

Rumah Sakit Pusat Angkatan Darat Gatot SoebrotoKeloid, Stem Cell

Start: 2021-10-01End: 2022-06-09Updated: 2023-07-11

Unknown Phase

Intravitreal Triamcinolone and Biomarkers in Rhegmatogenous Retinal Detachment

CompletedNCT07774182

Anggun Rama YudanthaProliferative Vitreoretinopathy in Rhegmatogenous Retinal Detachment

Start: 2025-05-06End: 2026-03-18Updated: 2026-08-19

Related Papers

Safety, Tolerability, and Pharmacokinetics of Same-Knee Intra-Articular Injection of Corticosteroid and Lorecivivint Within 7 Days: An Open-Label, Randomized, Parallel-Arm Study.

2023-10-302 citations